Kamada (KMDA)
NASDAQ:KMDA
$5.90
-$0.05(-0.84%)
KMDAKamada
$5.90
-$0.05 (-0.84%)

Kamada Stock Analysis & Ratings

Kamada Stock Analysis Overview

Smart Score
2
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Kamada stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, Data-Driven rating system and does not include human intervention.

Stock Chart

KMDA
$5.90
-$0.05 (-0.84%)

KMDA Stock Stats

Previous Close$5.95
Open$5.94
Bid5.93 x 100
Ask5.96 x 3000
Today’s Range$5.87 - $5.99
52-Week Range$5.55 - $13.33
Volume45.53K
Average Volume146.64K
Market Cap$264.00M
Beta1.01
P/E Ratio18.6
EPS0.64
Earnings DateAug 03, 2021

Company Description

Kamada

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
Sector
Healthcare
Industry
Drug Manufacturers
CEO
Amir London
Employees
408
Address
2 Holzman Street, Rehovot, 7670402, IL

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

KMDA FAQ

What was Kamada’s price range in the past 12 months?
Kamada lowest stock price was $5.55 and its highest was $13.33 in the past 12 months.
What is Kamada’s market cap?
Kamada’s market cap is $264.00M.
What is Kamada’s price target?
The average price target for Kamada is $11.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $11.00 ,the lowest forecast is $11.00. The average price target represents 86.44% Increase from the current price of $5.9.
What do analysts say about Kamada?
Kamada’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
When is Kamada’s upcoming earnings report date?
Kamada’s upcoming earnings report date is Aug 03, 2021 which is next month.
How were Kamada’s earnings last quarter?
Kamada released its earnings results on May 12, 2021. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.089 by -$0.029.
Is Kamada overvalued?
According to Wall Street analysts Kamada’s price is currently Undervalued.
Does Kamada pay dividends?
Kamada does not currently pay dividends.
What is Kamada’s EPS estimate?
Kamada’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kamada have?
Kamada has 44,750,000 shares outstanding.
What happened to Kamada’s price movement after its last earnings report?
Kamada reported an EPS of $0.06 in its last earnings report, missing expectations of $0.089. Following the earnings report the stock price went down -3.735%.
Which hedge fund is a major shareholder of Kamada?
Among the largest hedge funds holding Kamada’s share is ARK Investment Management LLC. It holds Kamada’s shares valued at 5M.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis